跳至主要内容
临床试验/NCT05031702
NCT05031702Unknown不适用

Effectiveness of the Assumption of a Supplement Based on the Extract From Camelia Leaf Sinensis on Basal Metabolism and Body Composition in Overweight Women or With Obesity in Postmenopause

Azienda di Servizi alla Persona di Pavia1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2021年3月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
32
试验地点
1
主要终点
Changes on energy expenditure

研究概览

简要总结

Camellia Sinensis leaf extract contributes to increasing energy expenditure and calorie consumption by increasing thermogenesis. The purpose of this study is to evaluate the efficacy of Camellia Sinensis on basal metabolism and body composition in overweight women or with obesity in postmenopause.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
50 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者
是

入选标准

  • •Postmenopause
  • •Overweight or obesity class I-II (Body Mass Index 25-39,9 Kg/m2)

排除标准

  • •Changes in heart rhythm
  • •Intolerance or allergy to components
  • •Obesity class III (Body Mass Index > 40 Kg/m2)

研究组 & 干预措施

Placebo

Placebo Comparator

Tablets of the same size as the active component

干预措施: Placebo (Combination Product)

Dietary supplement

Active Comparator

Extract from Camellia Sinensis leaf

干预措施: Camellia Sinensis leaf extract (Dietary Supplement)

结局指标

主要结局

Changes on energy expenditure

时间窗: Changes from baseline energy expenditure at 4 and at 8 weeks

Basal metabolic rate (Kcal/day)

次要结局

  • Changes on anthropometry(Changes from baseline anthropometry at 4 and at 8 weeks)
  • Changes on insulin resistance(Changes from baseline insulin resistance at 4 and at 8 weeks)
  • Changes on satiety(Changes of satiety through 8 weeks)
  • Changes on carbohydrate profile(Changes from baseline carbohydrate profile at 4 and at 8 weeks)
  • Changes on incidence of Treatment-Emergent Adverse Events [Safety and Tolerability](Changes from baseline incidence of Treatment-Emergent Adverse Events at 8 weeks)
  • Changes on citokine profile(Changes from baseline citokine profile at 4 and at 8 weeks)
  • Changes on inflammation(Changes from baseline inflammation at 8 weeks)
  • Changes on body composition(Changes from baseline body composition at 4 and at 8 weeks)
  • Changes on lipid profile(Changes from baseline lipid profile at 8 weeks)
  • Changes on plasma catecholamine profile(Changes from baseline plasma catecholamine profile at 4 and at 8 weeks)

研究者

发起方
Azienda di Servizi alla Persona di Pavia
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验